AliveDx Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 170

Employees

  • Share Price
  • $0.13
  • (As of Thursday Closing)

AliveDx General Information

Description

Manufacturer of conventional reagent products intended to help with blood grouping within the global transfusion diagnostics market. The company offers medical device, innovation, diagnostics, autoimmune diseases, in-vitro diagnostics, blood banking and disease screening.

Contact Information

Website
www.alivedx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Business Park Terre Bonne
  • Route de Crassier 13
  • 1262 Eysins
  • Switzerland
Primary Industry
Diagnostic Equipment
Corporate Office
  • Business Park Terre Bonne
  • Route de Crassier 13
  • 1262 Eysins
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AliveDx Stock Performance

As of 15-Jun-2023, AliveDx’s stock price is $0.13. Its current market cap is $2.74M with 21.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.13 $0.13 $0.02 - $18.37 $2.74M 21.1M 40.41 -$36.62

AliveDx Financials Summary

As of 31-Dec-2022, AliveDx has a trailing 12-month revenue of $37.4M.

In Thousands,
USD
TTM 31-Dec-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 248,911 294,504 444,549 378,844
Revenue 37,410 38,514 43,379 32,656
EBITDA (84,551) (85,052) (71,620) (65,629)
Net Income (124,030) (125,130) (111,032) (105,138)
Total Assets 119,326 193,989 219,812 226,738
Total Debt 272,394 266,526 194,859 180,923
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AliveDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AliveDx‘s full profile, request access.

Request a free trial

AliveDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of conventional reagent products intended to help with blood grouping within the global transfusion diagnos
Diagnostic Equipment
Eysins, Switzerland
170 As of 2013

Norcross, GA
 

Hercules, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AliveDx Competitors (17)

One of AliveDx’s 17 competitors is Immucor, a Formerly PE-Backed company based in Norcross, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immucor Formerly PE-Backed Norcross, GA
Bio-Rad Laboratories Corporation Hercules, CA
OncoCyte Formerly VC-backed Irvine, CA
Genomic Expression Venture Capital-Backed Beverly, MA
Abbott Corporation North Chicago, IL
You’re viewing 5 of 17 competitors. Get the full list »

AliveDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AliveDx ESG

Risk Overview

Risk Rating

Updated January, 05, 2023

21.21 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,638

Rank

Percentile

Healthcare

Industry

of 636

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view AliveDx’s complete esg history, request access »

AliveDx FAQs

  • When was AliveDx founded?

    AliveDx was founded in 2007.

  • Where is AliveDx headquartered?

    AliveDx is headquartered in Eysins, Switzerland.

  • What is the size of AliveDx?

    AliveDx has 170 total employees.

  • What industry is AliveDx in?

    AliveDx’s primary industry is Diagnostic Equipment.

  • Is AliveDx a private or public company?

    AliveDx is a Public company.

  • What is the current stock price of AliveDx?

    As of 15-Jun-2023 the stock price of AliveDx is $0.13.

  • What is the current market cap of AliveDx?

    The current market capitalization of AliveDx is $2.74M.

  • What is AliveDx’s current revenue?

    The trailing twelve month revenue for AliveDx is $37.4M.

  • Who are AliveDx’s competitors?

    Immucor, Bio-Rad Laboratories, OncoCyte, Genomic Expression, and Abbott are some of the 17 competitors of AliveDx.

  • What is AliveDx’s annual earnings per share (EPS)?

    AliveDx’s EPS for 12 months was -$36.62.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »